tirzepatide ckd Not currently a kidney therapy. But this exploratory finding is worth watching closely. 🫘 #ObesityMedicine #Tirzepatide #Type2Diabetes #KidneyHealth #ChronicKidneyDisease #GLP1 #GIP #CardiometabolicHealth #Nephrology #MetabolicHealth #CKD #T2DM Tirzepatide improves kidney outcomes in

Always discuss any new medications or supplements with a health professional, so you can make informed decisions that suit your individual needs and support lasting wellbeing

Bacteriostatic waters 0.9% benzyl alcohol lets the same vial be accessed repeatedly across 28 days without the solution losing sterility

Use in pregnancy and breastfeeding Rytary has not been well studied in patients who are pregnant or breastfeeding

Full SURMOUNT-1 trial results: nej.md/48VdDZp A 3-year study of tirzepatide in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo

20 : pp

For best results, consume 30-60 minutes before training